Normal-Weight Patients Seek Obesity Drugs for Body Shape, Doctor Warns

Some at a normal weight worry about fat in specific areas Losing weight does not target the spots people want to slim Surgeon says the real issue is body shape, not the scale

Culture|
|
By Lim Ji-hoonjhlim@sedaily.com
||
Clipart Korea - Seoul Economic Daily Culture News from South Korea
Clipart Korea

As obesity drugs gain popularity alongside a dieting boom in South Korea, concerns are mounting over misuse and overuse. Against that backdrop, a doctor has advised that concerns about weight and concerns about body shape should be treated as separate issues, pointing to people at a normal weight who seek the drugs to lose more.

Cho Jae-hyung, a surgeon at Line Culture Clinic, said recently that many people who feel they need to lose more weight despite being at a normal weight are actually troubled by specific areas such as their upper arms, lower abdomen or thighs, according to medical sources on the 20th. "In these cases, it is less a matter of weight than a matter of how fat is distributed," he said.

"Even if you lose weight, fat does not come off only in the areas you want," Cho said. "When people at a normal weight lose even more, fat may come off other areas first, producing results that differ from what they expected."

He expressed concern about prescription obesity treatments being used for dieting among people who are already at a normal weight. He said this concern reflects why the Ministry of Food and Drug Safety has designated GLP-1 obesity drugs such as Wegovy and Mounjaro as medicines at risk of misuse and overuse.

"It is natural for body shapes to differ from person to person, and having fat in a noticeable area does not mean it all needs correcting," Cho said. "A certain amount of fat also plays a role in creating the body's curves and natural lines."

"What matters in addressing body shape is not how much you take off, but deciding what to remove and what to keep," he added. "Looking closely at your own body, rather than at the number on the scale, is the first step toward reducing unnecessary treatment."

Original reporting by Lim Ji-hoon for Seoul Economic Daily.

AI-translated from Korean. Quotes from foreign sources are based on Korean-language reports and may not reflect exact original wording.

Watch · Seoul Economic Daily

More →
2:02
World News Day 2026 — Know the facts. Understand what matters. #ChooseTrustedJournalism

AI KEY

Preview
Korean Corporate Intelligence HubKOSPI · KOSDAQ · 12 sectors

A live, cap-weighted view of every KOSPI and KOSDAQ sector, with same-day Korean reporting distilled by company — built for foreign investors, correspondents and analysts who need to scan Korea before the next session.

Korea Company Atlas

Preview
Market Ontology · The Feedback LoopKFTC 2025 · 92 groups · 121,954 articles

An English ontology of the Korean market — how companies, the media, the government and the National Assembly move each other in a loop. Korea's named controlling persons and designated business groups are a mechanism, not a risk to be priced blind.

SIGNAL

Now live
English Edition · Capital MarketsM&A · IPO · PE · Fund Flows

SIGNAL English Edition is live — Korea's deal desk reporting in English. M&A, IPOs, private equity and fund flows, covered daily for global institutional investors. Browse free; subscriber-only scoops at the 50% intro rate.